Plenary: Prime Time, I, Monday, Morning Session

Plenary: Prime Time, I

Plenary: Prime Time

Plenary: Prime Time, I, Monday, Morning Session

Moderator(s)

• 

  Piyush Agarwal, MD

  Urologic Oncology Branch, National Cancer Institute

  Slides  
• 

  E. Crawford, MD

  University Of Colorado

Presenter(s)

• 

  Marc Dall'Era, MD

  University of California, Davis

Moderator(s)

• 

  Seth Lerner, MD, FACS

  Baylor College of Medicine
• 

  Kelvin Moses, MD

  Associate Professor
  Vanderbilt University Medical Center
• 

  Ganesh Raj, MD,PhD

  UT Southwestern Medical Center
• 

  Robert Reiter, MD

  UCLA
• 

  Alp Sener, MD, PhD

  Western University

  Slides  
• 

  Christopher Wood, MD,FACS

  The University of Texas MD Anderson Cancer Center

Panelist(s)

• 

  Bernard Bochner, MD, FACS

  MD
  Memorial Sloan Kettering Cancer Center

Debater - Con(s)

• JC

  Jonathan Coleman, MD

  Memorial Sloan Kettering Cancer Center

Panelist(s)

• 

  Leonard Gomella, MD,FACS

  Professor And Chair
  Thomas Jefferson University
• 

  Martin Sanda, MD

  Emory University School of Medicine

Surgeon(s)

• 

  Douglas Scherr, MD

  Weill Cornell Medical College-NY Presbyterian Hospital

Debater - Pro(s)

• 

  Samir Taneja, MD

  NYU Langone Medical Center

Panelist(s)

• 

  Willie Underwood, III, MD

  M.D., MSc., MPH
  Roswell Park Cancer Institute
• 

  Robert Uzzo, MD

  Chairman, Dept. of Surgical Oncology
  Fox Chase Cancer Center - Temple Health

Debater - Con(s)

• 

  Matthew Campbell, MD

  MD Anderson Cancer Center

Panelist(s)

• 

  Siamak Daneshmand, MD

  Associate Professor of Clinical Urology Director, Center for Urologic Oncology
  University of Southern California/Norris Comphrensive Cancer Center
• 

  Mark Frydenberg, MD

  Monash University
• 

  Alvin Goh, MD

  Memorial Sloan Kettering Cancer Center

Surgeon(s)

• GH

  Georges Pascal Haber, MD

  Cleveland Clinic

Debater - Pro(s)

• 

  Peter Pinto, MD

  National Cancer Institute, National Institutes of Health

Panelist(s)

• EV

  Eliezer Van Allen, MD

  Dana-Farber Cancer Institute
• 

  Christopher Warlick, MD, PhD

  University of Minnesota

Surgeon(s)

• TD

  Timothy Donahue, MD

Debater - Con(s)

• SE

  Scott Eggener, MD

Panelist(s)

• 

  Khurshid Guru, MD

  Director of Robohe Surgery
  Roswell Park Comprehensive Cancer Center
• 

  Joseph Ippolito, MD, PhD

  Washington University School of Medicine

Debater - Pro(s)

• 

  Chung-Han Lee, MD

  MSKCC

  Slides  

Panelist(s)

• 

  Herbert Lepor, MD

  Professor and Martin Spatz Chairman
  NYU School of Medicine
• 

  Thomas Polascik, MD, FACS

  Professor of Surgery
  Duke University

  Slides  
• 

  Walter Rayford, MD
• 

  John Barry, MD

  Oregon Health & Science University

Debater - Pro(s)

• 

  Alexander Kutikov, MD,FACS

  Fox Chase Cancer Center

Debater - Con(s)

• 

  Arturo Mendoza-Valdes, MD

  Hospital Medica Sur

Panelist(s)

• 

  Arnulf Stenzl, MD

  University of Tuebingen, Germany

  Slides  

Presentations:

• 7:30 AM - 7:40 AM

  Highlights: Society for Urologic Oncology (SUO) Program
  Marc Arnaldo Dall'Era, MD
• 7:40 AM - 8:10 AM

  Surgical Techniques: Partial Cystectomy
  Piyush K. Agarwal, MD; Douglas S. Scherr, MD – Weill Medical College of Cornell University; Georges Pascal Haber, MD – The Cleveland Clinic Foundation; Timothy F. Donahue, MD
• 8:10 AM - 8:40 AM

  Setbacks and Operative Solutions (SOS): Radical Cystectomy
  Seth Paul Lerner, MD, FACS; Bernard H. Bochner, MD, FACS – Memorial Sloan-Kettering Cancer Center; Alvin Chun Chin Goh, MD – Memorial Sloan Kettering Cancer Center; Khurshid A. Guru, MD; Arnulf Stenzl, MD
• 8:40 AM - 9:10 AM

  Panel Discussion: Prostate Cancer in African Americans
  Kelvin A. Moses, MD – Vanderbilt University Dept of Urology; Willie Underwood, III, MD – Roswell Park Cancer Inst Main Campus; Christopher A. Warlick, MD, PhD – University of Minnesota; Walter Rayford, MD
• 9:10 AM - 9:40 AM

  Panel Discussion: Urologic Malignancy and Transplant Patients: Special Considerations for Screening & Management
  Alp Sener, MD, PhD; Robert G. Uzzo, MD – Fox Chase Cancer Center; Siamak Daneshmand, MD; Herbert Lepor, MD – NYU Urology Associates; John M. Barry, MD
• 9:40 AM - 10:10 AM

  Crossfire: Controversies in Urology: Cytoreductive Radical Therapy still has a Role in the Era of Targeted Therapy for Metastatic RCC
  Christopher Griffith Wood, MD,FACS – UT MD Anderson Cancer Ctr.; Jonathan Andrew Coleman, MD – Memorial Sloan-Kettering Cancer Center; Matthew Campbell, MD; Chung-Han Lee, MD – Memorial Sloan Kettering Cancer Center; Alexander Kutikov, MD,FACS – Fox Chase Cancer Center
• 10:10 AM - 10:30 AM

  Panel Discussion: Enhanced PET imaging for High Risk and Advanced Prostate Cancer: Ready for Prime Time?
  Robert Evan Reiter, MD – UCLA Department of Urology; Martin George Sanda, MD – The Emory Clinic, Inc.; Mark Frydenberg, MD – Australian Urology Associates; Joseph Ippolito, MD, PhD
• 10:30 AM - 11:00 AM

  Crossfire: Controversies in Urology: MRI Targeted Therapies for Prostate Cancer: Ready for Prime Time?
  E. David Crawford, MD; Samir Taneja, MD – NYU Urology Associates; Peter Anthony Pinto, MD – NIH Clinical Center; Scott E. Eggener, MD; Arturo Mendoza-Valdes, MD – Hospital Medica Sur
• 11:00 AM - 11:30 AM

  Panel Discussion: Biomarkers in Prostate Cancer
  Ganesh V. Raj, MD,PhD; Leonard G. Gomella, MD,FACS – Thomas Jefferson University; Eliezer M. Van Allen, MD – Eliezer Van Allen Laboratory; Thomas James Polascik, MD, FACS – The Duke Health Center